Kyung Dong Pharmaceutical Statistics

Total Valuation

Kyung Dong Pharmaceutical has a market cap or net worth of KRW 167.31 billion. The enterprise value is 182.97 billion.

Market Cap	167.31B
Enterprise Value	182.97B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Kyung Dong Pharmaceutical has 26.94 million shares outstanding. The number of shares has increased by 0.25% in one year.

Shares Outstanding	26.94M
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	-0.52%
Owned by Insiders (%)	42.44%
Owned by Institutions (%)	1.10%
Float	12.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.94
PB Ratio	0.77
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.30
EV / Sales	1.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.04

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.25.

Current Ratio	1.26
Quick Ratio	0.70
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	-2.08
Interest Coverage	-15.57

Financial Efficiency

Return on equity (ROE) is -6.98% and return on invested capital (ROIC) is -4.04%.

Return on Equity (ROE)	-6.98%
Return on Assets (ROA)	-3.64%
Return on Capital (ROIC)	-4.04%
Revenue Per Employee	501.67M
Profits Per Employee	-45.48M
Employee Count	356
Asset Turnover	0.60
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.18%
50-Day Moving Average	6,498.40
200-Day Moving Average	6,504.00
Relative Strength Index (RSI)	42.66
Average Volume (20 Days)	25,674

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kyung Dong Pharmaceutical had revenue of KRW 178.59 billion and -16.19 billion in losses. Loss per share was -596.31.

Revenue	178.59B
Gross Profit	103.16B
Operating Income	-17.39B
Pretax Income	-12.30B
Net Income	-16.19B
EBITDA	-11.90B
EBIT	-17.39B
Loss Per Share	-596.31

Full Income Statement

Balance Sheet

The company has 38.61 billion in cash and 53.99 billion in debt, giving a net cash position of -15.38 billion or -570.76 per share.

Cash & Cash Equivalents	38.61B
Total Debt	53.99B
Net Cash	-15.38B
Net Cash Per Share	-570.76
Equity (Book Value)	218.43B
Book Value Per Share	8,096.88
Working Capital	21.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.80 billion and capital expenditures -7.17 billion, giving a free cash flow of -25.98 billion.

Operating Cash Flow	-18.80B
Capital Expenditures	-7.17B
Free Cash Flow	-25.98B
FCF Per Share	-964.12

Full Cash Flow Statement

Margins

Gross margin is 57.76%, with operating and profit margins of -9.74% and -9.07%.

Gross Margin	57.76%
Operating Margin	-9.74%
Pretax Margin	-6.88%
Profit Margin	-9.07%
EBITDA Margin	-6.67%
EBIT Margin	-9.74%
FCF Margin	-14.54%

Dividends & Yields

This stock pays an annual dividend of 400.00, which amounts to a dividend yield of 6.44%.

Dividend Per Share	400.00
Dividend Yield	6.44%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	6.19%
Earnings Yield	-9.60%
FCF Yield	-15.53%

Dividend Details

Stock Splits

The last stock split was on April 20, 2018. It was a forward split with a ratio of 2.

Last Split Date	Apr 20, 2018
Split Type	Forward
Split Ratio	2

Scores

Kyung Dong Pharmaceutical has an Altman Z-Score of 2.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.6
Piotroski F-Score	n/a